Benvenga V, Cuenod A, Purushothaman S, Dasen G, Weisser M, Bassetti S
Genome Med. 2024; 16(1):23.
PMID: 38317199
PMC: 10840241.
DOI: 10.1186/s13073-024-01292-w.
Senok A, Nassar R, Celiloglu H, Nabi A, Alfaresi M, Weber S
Sci Rep. 2020; 10(1):18551.
PMID: 33122734
PMC: 7596093.
DOI: 10.1038/s41598-020-75565-w.
Obasuyi O, McClure J, Oronsaye F, Akerele J, Conly J, Zhang K
Microorganisms. 2020; 8(6).
PMID: 32560236
PMC: 7356805.
DOI: 10.3390/microorganisms8060912.
Larsen J, Andersen P, Winstel V, Peschel A
J Antimicrob Chemother. 2017; 72(4):1002-1005.
PMID: 28088766
PMC: 5400086.
DOI: 10.1093/jac/dkw544.
Andrey D, Francois P, Manzano C, Bonetti E, Harbarth S, Schrenzel J
Eur J Clin Microbiol Infect Dis. 2016; 36(2):343-350.
PMID: 27744604
PMC: 5253141.
DOI: 10.1007/s10096-016-2807-5.
Rapid Bacterial Identification, Resistance, Virulence and Type Profiling using Selected Reaction Monitoring Mass Spectrometry.
Charretier Y, Dauwalder O, Franceschi C, Degout-Charmette E, Zambardi G, Cecchini T
Sci Rep. 2015; 5:13944.
PMID: 26350205
PMC: 4563557.
DOI: 10.1038/srep13944.
Molecular epidemiology of Methicillin-resistant Staphylococcus aureus in Africa: a systematic review.
Abdulgader S, Shittu A, Nicol M, Kaba M
Front Microbiol. 2015; 6:348.
PMID: 25983721
PMC: 4415431.
DOI: 10.3389/fmicb.2015.00348.
Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998.
Kelley W, Jousselin A, Barras C, Lelong E, Renzoni A
Antimicrob Agents Chemother. 2015; 59(4):1922-30.
PMID: 25583724
PMC: 4356817.
DOI: 10.1128/AAC.04068-14.
Recombinations in staphylococcal cassette chromosome mec elements compromise the molecular detection of methicillin resistance in Staphylococcus aureus.
Hill-Cawthorne G, Hudson L, El Ghany M, Piepenburg O, Nair M, Dodgson A
PLoS One. 2014; 9(6):e101419.
PMID: 24972080
PMC: 4074205.
DOI: 10.1371/journal.pone.0101419.
Molecular epidemiology and antimicrobial susceptibility of clinical Staphylococcus aureus from healthcare institutions in Ghana.
Egyir B, Guardabassi L, Sorum M, Nielsen S, Kolekang A, Frimpong E
PLoS One. 2014; 9(2):e89716.
PMID: 24586981
PMC: 3934920.
DOI: 10.1371/journal.pone.0089716.
A correlative analysis of epidemiologic and molecular characteristics of methicillin-resistant Staphylococcus aureus clones from diverse geographic locations with virulence measured by a Caenorhabditis elegans host model.
Wu K, Zhang K, McClure J, Zhang J, Schrenzel J, Francois P
Eur J Clin Microbiol Infect Dis. 2012; 32(1):33-42.
PMID: 22898726
PMC: 3545200.
DOI: 10.1007/s10096-012-1711-x.
Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus.
Vaudaux P, Ferry T, Uckay I, Francois P, Schrenzel J, Harbarth S
Eur J Clin Microbiol Infect Dis. 2012; 31(12):3367-74.
PMID: 22833247
DOI: 10.1007/s10096-012-1705-8.
High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.
Uckay I, Bernard L, Buzzi M, Harbarth S, Francois P, Huggler E
Antimicrob Agents Chemother. 2011; 56(3):1258-64.
PMID: 22155824
PMC: 3294919.
DOI: 10.1128/AAC.05808-11.
Neutrophils in innate host defense against Staphylococcus aureus infections.
Rigby K, DeLeo F
Semin Immunopathol. 2011; 34(2):237-59.
PMID: 22080185
PMC: 3271231.
DOI: 10.1007/s00281-011-0295-3.
Molecular and epidemiological evaluation of strain replacement in patients previously harboring gentamicin-resistant MRSA.
De Angelis G, Francois P, Lee A, Schrenzel J, Renzi G, Girard M
J Clin Microbiol. 2011; 49(11):3880-4.
PMID: 21918027
PMC: 3209128.
DOI: 10.1128/JCM.01061-11.
Community-Acquired Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections: Management and Prevention.
Chen L, Chastain C, Anderson D
Curr Infect Dis Rep. 2011; 13(5):442-50.
PMID: 21773687
DOI: 10.1007/s11908-011-0198-4.
Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach.
Fischer A, Yang S, Bayer A, Vaezzadeh A, Herzig S, Stenz L
J Antimicrob Chemother. 2011; 66(8):1696-711.
PMID: 21622973
PMC: 3133485.
DOI: 10.1093/jac/dkr195.
A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus.
Monecke S, Coombs G, Shore A, Coleman D, Akpaka P, Borg M
PLoS One. 2011; 6(4):e17936.
PMID: 21494333
PMC: 3071808.
DOI: 10.1371/journal.pone.0017936.
Changing epidemiology of methicillin-resistant Staphylococcus aureus in Iceland from 2000 to 2008: a challenge to current guidelines.
Holzknecht B, Hardardottir H, Haraldsson G, Westh H, Valsdottir F, Boye K
J Clin Microbiol. 2010; 48(11):4221-7.
PMID: 20844224
PMC: 3020889.
DOI: 10.1128/JCM.01382-10.
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.
David M, Daum R
Clin Microbiol Rev. 2010; 23(3):616-87.
PMID: 20610826
PMC: 2901661.
DOI: 10.1128/CMR.00081-09.